A day-long symposium focused on Medicinal Chemistry, Organic Synthesis, and Methodology, featuring eminent scientists from industry and academia. |
||
Time | Speaker/Session | |
---|---|---|
07:30 AM | Symposium Registration Opens – Refreshments | |
Opening Remarks | ||
08:45 AM | Welcome to the Symposium: Raj Rajur, CreaGen Inc., Chair, Medicinal Chemistry NESACS | |
Morning Session Chair: Paul Scola (BMS) | ||
09:00 AM | Keynote Presentation: Jennifer A. Dounda, Nobel Laureate, U.C. Berkeley Title: CRISPR Biology and Biotechnology: When Will Genome Editing Transform Healthcare |
|
09:50 AM | Neelu Kaila, Nimbus Therapeutics Title: Discovery of NDI-101150, A highly potent and selective HPK1 inhibitor for the treatment of cancer, through structure-based drug design |
|
10:40 AM to 11:10 AM | Networking break in the Exhibition Forum with refreshments & food | |
11:10 AM | John Tallarico, Novartis Title: Chemical Biology for Precision Medicines |
|
12:00 PM - 02:00 PM | Lunch Break – On Your Own | |
Afternoon Session Chair: TBA | ||
02:00 PM | Courtney Roberts, Univ. Minnesota Title: Access to “Inaccessible” Arynes and their Potential for Rethinking Heterocycle Synthesis |
|
02:50 PM | Brian Raymer, Alkermes Title: First Disclosure of ALKS 2680: An Orexin 2 Receptor Agonist in Development for Central Disorders of Hypersomnolence |
|
03:40 PM to 4:10 PM | Networking break in Exhibition Forum with refreshments & food | |
04:10 PM |
Keynote Presentation: Huw Davis, Emory University Title: Pharmaceutical Applications of Rhodium-Catalyzed Reactions of Donor/Acceptor |
|
Social Event & Networking | ||
05:00 PM | Closing remarks and opening of Social Event – NESACS | |
05:00 PM - 06:00 PM | Social Networking with refreshments, food & Raffle |
Registration Link: https://nemedchem.org/conference/
For additional details, please contact any of the Organizing Committee:
Raj Rajur (Chair) (rrajur@creagenbio.com); Mark Ashwell (mashwellmail@gmail.com); Brian Aquila (BrianAquila@alkermes.com); Jason Beiger (jason.beiger@takeda.com); Peter Fuller (peter.fuller@merck.com); Paul Greenspan (pgreenspan62@gmail.com); Melissa Grenier-Davies (melissa.c.grenier@gsk.com); Michelle Lamb (Michelle.Lamb@astrazeneca.com); Silvana Leit de Moradei (silvana.leit@nimbustx.com); Blaise Lippa (Blaise.Lippa@morphictx.com); Lauren Monovich (lauren.monovich@novartis.com); Andrew Scholte (Andrew.Scholte@genzyme.com); Paul Scola (Paul.Scola@bms.com)